Cargando…
2776. Decrease in ceftriaxone treatment failure rates for infections caused by inducible AmpC producing Enterobacterales associated with changes in laboratory susceptibility testing reporting
BACKGROUND: Due to the risk of AmpC induction and subsequent emergence of resistance on therapy, IDSA guidelines suggest avoiding ceftriaxone (CRO) for the treatment of E. cloacae, K. aerogenes or C. freundii (CEK group) but not for S. marcescens (SM), citing the lack of evidence. Many clinical labo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678767/ http://dx.doi.org/10.1093/ofid/ofad500.2387 |